Vaxcyte PCVX
NASDAQ PCVX
$56.48 +0.43 (+0.77%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Vaxcyte's Return on Capital Employed [ROCE] came in at -39.21% for Q2 2026, down 16.96 percentage points from -22.25% a year earlier and down 2.09 percentage points from the prior quarter.

Analysis

Vaxcyte (PCVX) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Vaxcyte's Return on Capital Employed [ROCE] was -30.27%, down 5.72 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of +18.84 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -24.56% in FY2024 (+19.53 pp), -44.08% in FY2023 (-6.91 pp), -37.18% in FY2022 (-5.75 pp) and -31.43% in FY2021 (+17.68 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q3 2022.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of -1.80 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2023 (a gain of 21.80 percentage points), and the weakest in Q1 2026 (a drop of 18.12 percentage points).
  • Business Quant data shows PCVX's Return on Capital Employed [ROCE] at -37.11% (Q1 2026), -32.06% (Q4 2025) and -26.71% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Vaxcyte 8.18 Bn 8.18 Bn - -39.21%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -39.21%
Mar 31, 2026 -37.11%
Dec 31, 2025 -32.06%
Sep 30, 2025 -26.71%
Jun 30, 2025 -22.25%
Mar 31, 2025 -18.99%
Dec 31, 2024 -16.77%
Sep 30, 2024 -22.37%
Jun 30, 2024 -28.77%
Mar 31, 2024 -30.76%
Dec 31, 2023 -35.82%
Sep 30, 2023 -25.32%
Jun 30, 2023 -25.39%
Mar 31, 2023 -27.68%
Dec 31, 2022 -34.74%
Sep 30, 2022 -47.12%
Jun 30, 2022 -38.20%
Mar 31, 2022 -35.61%
Dec 31, 2021 -33.39%
Sep 30, 2021 -30.23%
API Access

Vaxcyte Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PCVX&period=max&api_key=YOUR_API_KEY